Stocks: 503 Market Cap: $51.2T S&P 500: 5,954.50 +0.82%
500 500Market
Amgen
AMGN Rank #51 Health Care
$384.71 -0.89%

Key Statistics

Market Cap
$207.39B
Volume (24h)
$1.1B
P/E Ratio
27.0
EPS
$14.25
1 Day
-0.89%
7 Day
+2.66%
YTD
+5.32%
Sector
Health Care
S&P 500 Rank
#51
52W Low: $333.47 52W High: $451.34

About Amgen

Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics. The company's key products include Enbrel (etanercept) for rheumatoid arthritis and psoriasis, Neulasta (pegfilgrastim) for neutropenia, and Repatha (evolocumab) for hypercholesterolemia. As a leader in the biotechnology industry, Amgen's treatments improve the lives of millions of patients worldwide.

Latest News

Loading latest news...

Sector Peers — Health Care

LLY — Lilly (Eli) $1,027.59 -2.32% JNJ — Johnson & Johnson $247.67 -0.31% ABBV — AbbVie $233.22 +0.49% MRK — Merck & Co. $121.20 -2.11% UNH — UnitedHealth Group $290.56 -0.92% ABT — Abbott Laboratories $114.46 -1.62% TMO — Thermo Fisher Scientific $506.43 -2.82% GILD — Gilead Sciences $149.58 +0.42% View all Health Care stocks →

Daily Market Brief

S&P 500 closing prices, top movers, and sector performance — delivered daily.